Search

Displaying results 4381 - 4390 of 10000 in total
  1. Drug

    Neluxicapone

    go.drugbank.com/drugs/DB21445
    Experimental

    Neluxicapone is a small molecule drug. Neluxicapone has a monoisotopic molecular weight of 264.09 Da.

  2. Drug

    Lonodelestat

    go.drugbank.com/drugs/DB21452
    Experimental

    Lonodelestat is a small molecule drug. The usage of the INN stem '-elestat' in the name indicates that Lonodelestat is a elastase inhibitor. … Lonodelestat has a monoisotopic molecular weight of 1477.82 Da.

  3. Drug

    Milategrast

    go.drugbank.com/drugs/DB21461
    Experimental

    Milategrast is a small molecule drug. Milategrast has a monoisotopic molecular weight of 354.3 Da.

  4. Drug

    Amniotic membrane

    go.drugbank.com/drugs/DB33970
    Experimental

    Amniotic membrane is a biologic drug. … Amniotic membrane is under investigation in clinical trial NCT07824596 (The Role of Amniotic Membrane in Promoting Rapid Recovery of Buccal Mucosal Defect After Harvesting Oral Mucosa for Urethral Reconstruction

  5. Drug

    MGC030

    go.drugbank.com/drugs/DB33973
    Experimental

    MGC030 is a biologic drug. MGC030 is under investigation in clinical trial NCT07822399 (A Study of MGC030 in Participants With Advanced Solid Tumors).

  6. Drug

    VH5356136

    go.drugbank.com/drugs/DB33975
    Experimental

    VH5356136 is a small molecule drug. … VH5356136 is under investigation in clinical trial NCT07822477 (A Study to Investigate Safety, Tolerability and Pharmacokinetics of VH5356136 in Adult Participants Without HIV).

  7. Drug

    MWN117

    go.drugbank.com/drugs/DB33969
    Experimental

    MWN117 is a small molecule drug. MWN117 is under investigation in clinical trial NCT07824804 (Phase 1 Clinical Study of MWN117 Injection in Healthy Participants and Participants With Obesity).

  8. Drug

    CM583

    go.drugbank.com/drugs/DB33976
    Experimental

    CM583 is a small molecule drug. CM583 is under investigation in clinical trial NCT07823764 (Study of CM583 in Healthy Participants).

  9. Drug

    Patisiran

    go.drugbank.com/drugs/DB14582
    Approved

    It is marketed as Onpattro which is formulated as patisiran within a liposome envelope for better delivery to the liver, where transthyretin is produced. … Patisiran is a first in class short interfering RNA for the treatment of patients with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis [L4220].

    Categories: Compounds used in a research, industrial, or household setting
  10. Drug

    Floxuridine

    go.drugbank.com/drugs/DB00322
    ApprovedInvestigational

    An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection. Floxuridine is available as a sterile, nonpyrogenic, lyophilized powder for reconstitution. … When administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate.

    Synonyms: 1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil, 1-beta-D-2'-Deoxyribofuranosyl-5-flurouracilCategories: Cytochrome P-450 CYP2C9 Inhibitors, Heterocyclic Compounds, 1-Ring